SBIR Banner

You are here

Home  \  News & Events  \  Events  \  NCI SBIR Virtual MedTech Showcase & Partnering Meeting

NCI SBIR Virtual MedTech Showcase & Partnering Meeting

September 9, 2020 - September 10, 2020
Virtual

Request to Register

This September, the National Cancer Institute Small Business Innovation Research Development Center (NCI SBIR) is showcasing its MedTech portfolio virtually for the first time and you are cordially invited to attend to learn more about and meet with our innovative portfolio companies.

About the Event

If you are a MedTech investor or strategic partner interested in learning more about the top NCI SBIR-funded MedTech companies for potential investments and partnerships, join us September 9-10 for this virtual showcase that will include:

  • Showcase company profiles consisting of pre-recorded video pitches, executive summaries, and more
  • Keynote Address by NCI Director Ned Sharpless who will highlight NCI’s newest initiatives, including its program on serological testing to meet the needs of the COVID-19 crisis
  • Two days of virtual one-on-one partnering meetings
  • Panel discussion with MedTech investors and partners focused on opportunities and trends in MedTech investments and partnerships

The event platform will open around one month ahead of time so attendees and showcase companies can begin browsing profiles, networking, and requesting partnering meetings that will take place during the event. 

When your registration request is approved, you will receive an email from the event system asking you to log in and fill out your profile. Registration is complimentary.

 

About the Companies: Selected by Two Rounds of Reviews

The event will showcase 20-30 of the top MedTech startups that were not only selected by peer review for NCI funding, but were additionally selected for this event by a panel of more than 70 investors and partners based on the technology's level of innovation and the company's readiness to pitch, establish partnerships, and raise funding.

 

TENTATIVE AGENDA (All times in EDT)

DAY 1 (September 9, 2020)

TIME

SESSION

All Day

Partnering Meetings

12:00 p.m. - 12:30 p.m.

Keynote Address: Ned Sharpless, Director of the National Cancer Institute

12:30 p.m. - 1:00 p.m.

Overview of the Showcase and NCI SBIR/STTR Programs

 

DAY 2 (September 10, 2020)

TIME

SESSION

All Day

Partnering Meetings

3:30 p.m. - 4:45 p.m.

MedTech Investment Panel

  • Moderator: Paul Grand, Founder & CEO of MedTech Innovator
  • Aaron Sandoski, Norwich Ventures
  • Darshana Zaveri, Catalyst Health Ventures
  • Ibraheem Badejo, J&J Innovation

4:45 p.m. - 5:00 p.m.

Closing Remarks

 

About NCI SBIR

NCI SBIR is NCI's engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. NCI SBIR is one of the largest sources of early stage funding for life sciences companies operating in the cancer space. At any given time, our portfolio consists of more than 200 companies developing diagnostics, medical devices, research tools, and health IT tools among a total portfolio of more than 400 companies.

Learn more: https://sbir.cancer.gov/

 

If you have any questions or have trouble requesting to register, please email Brittany Connors at brittany.connors@nih.gov.